OpenAI Rival Anthropic Taps Instagram Co-Founder as Product Head

(Bloomberg) -- Artificial intelligence startup Anthropic hired Instagram co-founder Mike Krieger to be its new product chief, part of a broader push to bring its AI services to more users and businesses.

Most Read from Bloomberg

• Iran State TV Says ‘No Sign of Life’ at Helicopter Crash Site

• Speedier Wall Street Trades Are Putting Global Finance On Edge

• Hims Debuts $199 Weight-Loss Shots at 85% Discount to Wegovy

• Jamie Dimon Says Succession at JPMorgan Is ‘Well on the Way’

• One of the Last Big Bears on Wall Street Turns Bullish on US Stocks

Krieger, who previously served as chief technology officer at Meta Platforms Inc.-owned Instagram, will oversee Anthropic’s product engineering, product management and design functions, the company said in a blog post on Wednesday. Krieger will help “expand our suite of enterprise applications and bring Claude to a wider audience,” the company said.

Founded by ex-OpenAI employees in 2021, Anthropic has emerged as a primary rival to the ChatGPT maker by focusing on developing AI responsibly. Like OpenAI and other AI companies, Anthropic has also increasingly focused on selling its chatbot, Claude, to businesses in an effort to monetize the emerging technology.

“Mike’s background in developing intuitive products and user experiences will be invaluable as we create new ways for people to interact with Claude, particularly in the workplace,” Dario Amodei, co-founder and chief executive officer of Anthropic, said in the blog post.

Krieger and Kevin Systrom founded Instagram in 2010 and sold it to Meta, then Facebook, two years later. After leaving Facebook, the co-founders launched Artifact, a personalized news app. Last month, Artifact was acquired by Yahoo.

Most Read from Bloomberg Businessweek

• Netflix Had a Password-Sharing Problem. Greg Peters Fixed It

• Millennium Covets Citadel-Size Commodities Gains, Just Not the Risk

• Apple Puts Rival App Stores Behind a Tall Barricade

• Neuralink’s First Patient: ‘It Blows My Mind So Much’

• Walgreens and CVS Are Trying to Fix America’s Flailing Pharmacies

©2024 Bloomberg L.P.